Inactive Instrument
Quotes Chromadex Corp OTC Bulletin Board
Stocks
CDXC
US1710771007
Biotechnology & Medical Research
|
End-of-day quote
OTC Bulletin Board
|
||
| - USD | - |
|
| 11-05 | Niagen Bioscience, Inc., Q3 2026 Earnings Call, Nov 04, 2026 | |
| 11-05 | Niagen Bioscience, Inc. Provides Earnings Guidance for the Year 2026 | CI |
Stock exchange
OTC Bulletin Board
CDXC - $
-
0
$
Basic data
Market Cap (USD)
164,283,279
Net sales (USD)
129,423,000
Free-Float
70.57%
Free-Float capitalization (USD)
115,692,443
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 164M | |
| +2.24% | +8.40% | +58.47% | +69.00% | 66.7B | |
| +4.66% | +8.90% | +16.93% | +85.41% | 56.88B | |
| -0.60% | +1.73% | +24.32% | +94.40% | 56.53B | |
| +2.55% | +15.52% | +30.43% | +120.17% | 46.49B | |
| +2.58% | +7.89% | +32.49% | +45.30% | 44.8B | |
| +4.09% | +6.37% | +228.06% | +899.75% | 41.59B | |
| -0.47% | +9.38% | +27.53% | +52.40% | 35.35B | |
| +3.80% | -1.00% | +98.16% | +66.79% | 33.29B | |
| +1.48% | +6.21% | -38.80% | +395.73% | 25.1B | |
| Average | +2.26% | +6.63% | +53.07% | +203.21% | 41B | |
| Weighted average by Cap. | +2.29% | +7.27% | +53.75% | +181.55% |
Historical Quotes: Chromadex Corp
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
- Stock Market
- Stocks
- NAGE Stock
- CDXC Stock
- Quotes Chromadex Corp
Select your edition
All financial news and data tailored to specific country editions
